BACKGROUND: Steroid-free immunosuppression after liver transplantation (OLT) is effective and safe in the short and mid terms. However, research has shown a higher risk for late fibrosis among pediatric liver transplant recipients who have steroids withdrawn. Our aim was to test this hypothesis in the adult population. PATIENTS AND METHODS: The study involved 27 adults, 14 of whom were on a regimen of cyclosporine, azathioprine, and steroid (group A) and 13 cyclosporine and azathioprine steroid-free immunosuppression (group B). The main end point of the study was liver graft histology in the late stage after OLT, with emphasis on the evolution of fibrosis, which was scored according to Ishak. The secondary end points were patient and graft survivals, liver and kidney functions, rejection rates, infections, and tumors, as well as the incidences of cardiovascular and metabolic complications. RESULTS: After a mean follow-up of 89.3 +/- 21 months, the mean fibrosis scores did not differ between the 2 groups (2.2 +/- 1.5 vs 1.9 +/- 1.2; P = NS). One group A patient developed a severe acute rejection episode. The 7-year patient and graft survivals, as well as liver and kidney functions, incidence of infections, and cardiovascular and metabolic complications were comparable. Patients receiving steroids showed a trend toward an higher rate of de novo malignancies. CONCLUSION: Steroid-free immunosuppression did not increase the risk of graft fibrosis in the long term. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Manzia, T.m., Toti, L., Angelico, R., Di Cocco, P., Orlando, G., Tisone, G. (2010). Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis. TRANSPLANTATION PROCEEDINGS, 1237-1239 [10.1016/j.transproceed.2010.03.118].

Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis.

MANZIA, TOMMASO MARIA;TOTI, LUCA;Angelico R;TISONE, GIUSEPPE
2010-01-01

Abstract

BACKGROUND: Steroid-free immunosuppression after liver transplantation (OLT) is effective and safe in the short and mid terms. However, research has shown a higher risk for late fibrosis among pediatric liver transplant recipients who have steroids withdrawn. Our aim was to test this hypothesis in the adult population. PATIENTS AND METHODS: The study involved 27 adults, 14 of whom were on a regimen of cyclosporine, azathioprine, and steroid (group A) and 13 cyclosporine and azathioprine steroid-free immunosuppression (group B). The main end point of the study was liver graft histology in the late stage after OLT, with emphasis on the evolution of fibrosis, which was scored according to Ishak. The secondary end points were patient and graft survivals, liver and kidney functions, rejection rates, infections, and tumors, as well as the incidences of cardiovascular and metabolic complications. RESULTS: After a mean follow-up of 89.3 +/- 21 months, the mean fibrosis scores did not differ between the 2 groups (2.2 +/- 1.5 vs 1.9 +/- 1.2; P = NS). One group A patient developed a severe acute rejection episode. The 7-year patient and graft survivals, as well as liver and kidney functions, incidence of infections, and cardiovascular and metabolic complications were comparable. Patients receiving steroids showed a trend toward an higher rate of de novo malignancies. CONCLUSION: Steroid-free immunosuppression did not increase the risk of graft fibrosis in the long term. Copyright (c) 2010 Elsevier Inc. All rights reserved.
2010
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/18 - CHIRURGIA GENERALE
English
Con Impact Factor ISI
Manzia, T.m., Toti, L., Angelico, R., Di Cocco, P., Orlando, G., Tisone, G. (2010). Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis. TRANSPLANTATION PROCEEDINGS, 1237-1239 [10.1016/j.transproceed.2010.03.118].
Manzia, Tm; Toti, L; Angelico, R; Di Cocco, P; Orlando, G; Tisone, G
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

Questo articolo è pubblicato sotto una Licenza Licenza Creative Commons Creative Commons

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/22107
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 3
social impact